Bharat Biotech completes enrollment of 25,800 volunteers for Covaxin Phase-3 trials
Hyderabad: Bharat Biotech has completed enrollment of 25,800 volunteers for the Phase-3 trials of its COVID-19 vaccine Covaxin. This information ...
Read moreHyderabad: Bharat Biotech has completed enrollment of 25,800 volunteers for the Phase-3 trials of its COVID-19 vaccine Covaxin. This information ...
Read moreHyderabad: Bharat Biotech has been accorded emergency use authorisation from the drug regulator for its COVID-19 vaccine Covaxin. The company ...
Read moreHyderabad: Bharat Biotech Saturday announced successful recruitment of 23,000 volunteers, and continued progress towards achieving the goal of 26,000 participants ...
Read moreNew Delhi: The AIIMS here is unable to find the required number of volunteers for the phase-3 trial of Bharat ...
Read moreKolkata: West Bengal Urban development Minister Firhad Hakim became the first volunteer to take a shot of the COVID-19 vaccine,0 ...
Read moreBhubaneswar: The third phase of the human of the indigenous COVID-19 vaccine COVAXIN, will commence at a private hospital here ...
Read morePuri: The district administration along with various social outfits and volunteers Saturday carried out beach cleaning at around 50 places ...
Read moreBhubaneswar: Preparations are underway at a hospital here for the commencement of the second phase of human clinical trial of ...
Read moreMoscow: Russian university, Sechenov First Moscow State Medical University, has claimed the clinical trials of the world’s first vaccine against ...
Read moreLondon: There has been a decline in COVID-19 infection rate in the United Kingdom. Due to it the team at ...
Read more